
David Giljohann
Chief Executive Officer, AuraSense Therapeutics LLC, Skokie, IL, USA.
False
Chief Executive Officer, AuraSense Therapeutics LLC, Skokie, IL, USA.
Emphasis: We are developing biofunctionalized nanoparticles for gene regulation and detection. Our “Smart-Flares” are now being sold commercially by Merck-Millipore.”
Advice: “Commercializing technology is a rush. There is tremendous feeling of accomplishment to see a project turn into a product you can buy.”
Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.
False
False
False